Mainstreet eyes more ‘crowdfunding’ for nursing homes
After raising $1.8 million via the Internet for a new nursing home in Bloomington, the Carmel-based developer thinks it has found a more efficient source of fundraising for further construction.
Health Care & Life Sciences
Articles
Why are we so fat? Our food, health care are so cheap
Two new studies show that Americans have every economic incentive to consume too much food and then, when that overeating creates health problems for them, to consume lots of health care to fix it.
Shinseki resigns amid veterans’ health care issues
Veterans Affairs Secretary Eric Shinseki resigned Friday after publicly apologizing for systemic problems plaguing the agency's health care system.
Costly drugs force cancer docs to weigh price with therapy
With new cancer drugs priced as high as $10,000 a month, and insurers tightening payment rules, patients who thought they were well covered increasingly find themselves having to make life-altering decisions about what they can afford.
IU medical school helping to lead $30M concussion study
The Indiana University School of Medicine will help oversee a three-year, $30 million concussion study being funded by the Indianapolis-based NCAA and the U.S. Defense Department.
Pence’s HIP 2.0 plan gets kudos at first public hearing
Health care professionals and advocates for the poor voiced praise and support Wednesday for a plan by Gov. Mike Pence to expand the state’s Healthy Indiana Plan to provide more insurance coverage to Hoosiers.
Rotten Teeth Report Card
Indiana ranks 10th in the nation for the highest spending on health care and 10th in the nation for the number of adults missing six or more teeth. That’s not a coincidence. Hoosiers do a poor job of taking care of themselves, and we end up paying for it in higher taxes and health insurance premiums.
Teamwork transforming care at IU Health’s Saxony hospital
Getting everyone into the same room prior to surgeries is cutting costs and improving health.
OurHealth to add employer clinics, 450 jobs by 2018
The 5-year-old firm has pledged to invest $20 million to double the size of its corporate headquarters in Indianapolis and lease real estate for a series of 3,500-square-foot health clinics across the state.
Lilly, Sanofi seek to sell erection drug Cialis without prescription
Sanofi will apply for approval of Cialis as an over-the-counter treatment in the United States, Europe, Canada and Australia. The drug garnered $2.16 billion in sales last year.
Isotope maker plans $40M project in Noblesville
Radiopharmaceuticals maker Zevacor Molecular plans to open a $40 million isotope-production facility in Noblesville, creating nearly 50 good-paying jobs within five years.
Donnelly says Indiana’s VA sites not as troubled
U.S. Sen. Joe Donnelly said administrators at Indiana's VA hospitals have told him they don't have the same kind of problems as the 26 veterans facilities across the country facing complaints about long waits and backlogs.
Pfizer pulls plug on push to buy AstraZeneca
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry's history.
Hearings set for Healthy Indiana Plan expansion
Two public hearings are scheduled this week on Gov. Mike Pence's plan to use Medicaid funds to expand the Healthy Indiana Plan to provide insurance under the federal health care overhaul.
Ex-Lilly partner wins latest suit over Actos’ cancer risk
Takeda Pharmaceutical was found not liable for the bladder cancer of two women who used its Actos diabetes medication in the company’s latest trial over the drug. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.
Dropping health plan for Obamacare, this firm saved money but sacrificed choice
RANAC Corp., a small firm in Indianapolis, cut its spending on health benefits 25 percent after dropping its group health plan. Could it be a sign of things to come?
Takeda denies hiding Actos cancer risks in Nevada trial
Takeda Pharmaceutical Co. didn’t hide the alleged bladder-cancer risks of its diabetes medicine Actos, a lawyer for the company told a jury. Actos was marketed for Takeda in the United States by Eli Lilly and Co. from July 1999 to March 2006.
Pence pitches health plan proposal in Washington
The health insurance expansion Gov. Mike Pence is touting relies on federal Medicaid money and meets federal Medicaid requirements, but the Republican governor insists it's not Medicaid.
Drugmaker hid diabetes drug’s cancer risks, lawyer says
Takeda Pharmaceutical Co. executives covered up the cancer risks of its diabetes medicine Actos to protect billions of dollars in sales, a lawyer for two women argued.
Indiana’s Obamacare rates for 2015 all over the map
Initial 2015 premiums filed for the Obamacare exchanges in Indiana ranged from as high as a 46-percent hike to as low as a 9-percent cut. Anthem Blue Cross and Blue Shield wants an average increase of 9.7 percent.